← All trials
NCT00698607
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2008
- Primary completion
- Apr 1, 2010
- Completion date
- Apr 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 1466
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Seoul National UniversityLead sponsor
- Yonsei UniversityStudy chair
- Sungkyunkwan UniversityStudy chair
- Yonsei UniversityOverall official - principal investigator
- Chonnam National UniversityOverall official - principal investigator
- Inje UniversityOverall official - principal investigator
- Korea UniversityOverall official - principal investigator
- Seoul National UniversityOverall official - principal investigator
- Seoul National UniversityStudy chair
- AbbottCollaborator
- Boston Scientific CorporationCollaborator
- Ilsan HospitalOverall official - principal investigator
- Gachon UniversityStudy chair
- Hallym UniversityOverall official - principal investigator
- Ewha Womans UniversityOverall official - principal investigator
- Pusan National UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.